Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug.

A facile and simplified method was developed for the synthesis of 3D cubic mesoporous SBA-16 with both a spherical morphology and controllable pore size. The addition of CTAB during the synthesis allowed not only good control over the macroscopic morphology but also a significant reduction in the synthesis time. Notably, the pore size can simultaneously be adjusted by simply controlling the heating temperature. The pharmaceutical performance of the resulting SBA-16 for the delivery of the water-insoluble drug indomethacin (IMC), a non-steroidal anti-inflammatory agent used as a model drug, was systematically studied using nitrogen adsorption, powder X-ray diffraction, differential scanning calorimetry, infrared spectrometry and in vitro dissolution investigations. It was found that IMC could be effectively loaded into mesoporous SBA-16 via the solvent deposition method. An altered physical state and a marked improvement in the dissolution rate were observed for IMC after being loaded into SBA-16 microspheres. In particular, SBA-16 microspheres with the largest pore size (9.0 nm) and highly open and accessible pore networks exhibited the fastest drug release profile. We envisage that the improved drug delivery profiles obtained using SBA-16 as described in our work will offer an interesting option for the formulation of poorly water-soluble drugs.

[1]  C. A. Russell,et al.  Cationic phosphorus-carbon-pnictogen cages isolobal to [C5R5]+. , 2006, Chemical Communications.

[2]  G. Mul,et al.  Mesoporous silica material TUD-1 as a drug delivery system. , 2007, International journal of pharmaceutics.

[3]  Jenny Andersson,et al.  Influences of Material Characteristics on Ibuprofen Drug Loading and Release Profiles from Ordered Micro- and Mesoporous Silica Matrices , 2004 .

[4]  Patrick Augustijns,et al.  Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. , 2007, Chemical communications.

[5]  Ö. Dag,et al.  The effect of cationic surfactant and some organic/inorganic additives on the morphology of mesostructured silica templated by pluronics , 2008 .

[6]  María Vallet-Regí,et al.  Sol-gel silica-based biomaterials and bone tissue regeneration. , 2010, Acta biomaterialia.

[7]  Xiaofen Li,et al.  Bio-templated synthesis of highly ordered macro-mesoporous silica material for sustained drug delivery , 2010 .

[8]  Yuhan Sun,et al.  Controllable release of ibuprofen from size-adjustable and surface hydrophobic mesoporous silica spheres , 2009 .

[9]  G. Kalies,et al.  Liquid adsorption of n-octane/octanol/ethanol on SBA-16 silica. , 2007, Journal of colloid and interface science.

[10]  I. Smirnova,et al.  Adsorption of Drugs on Silica Aerogels , 2003 .

[11]  H. Santos,et al.  Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  T. Asefa,et al.  Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs. , 2010, ACS nano.

[13]  Qinghu Tang,et al.  Mesostructured SBA-16 with excellent hydrothermal, thermal and mechanical stabilities: modified synthesis and its catalytic application. , 2009, Journal of colloid and interface science.

[14]  J. M. Córdoba,et al.  Influence of synthesis temperature on morphology of SBA-16 mesoporous materials with a three-dimensional pore system , 2010 .

[15]  Thomas Rades,et al.  Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[16]  P. Kallinteri,et al.  Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles. , 2010, International journal of pharmaceutics.

[17]  María Vallet-Regí,et al.  Drug delivery from ordered mesoporous matrices , 2009, Expert opinion on drug delivery.

[18]  M. Jaroniec,et al.  Tailoring the Pore Structure of SBA-16 Silica Molecular Sieve through the Use of Copolymer Blends and Control of Synthesis Temperature and Time , 2004 .

[19]  R. Denoyel,et al.  Impregnation of vitamin E acetate on silica mesoporous phases using supercritical carbon dioxide , 2009 .

[20]  He Hui,et al.  Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. , 2010, Molecular pharmaceutics.

[21]  F. Marmottini,et al.  Role of mesoporous silicates on carbamazepine dissolution rate enhancement , 2008 .

[22]  D. Quintanar-Guerrero,et al.  Silica xerogels as pharmaceutical drug carriers , 2009 .

[23]  E. Rivera-Muñoz,et al.  Sol Gel-Derived SBA-16 Mesoporous Material , 2010, International journal of molecular sciences.

[24]  A. Garjani,et al.  Enhancement of Dissolution Rate and Anti-inflammatory Effects of Piroxicam Using Solvent Deposition Technique , 2002, Drug development and industrial pharmacy.

[25]  Bruno C. Hancock,et al.  What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.

[26]  Ludo Froyen,et al.  Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[27]  G. van Tendeloo,et al.  Investigation of the morphology of the mesoporous SBA-16 and SBA-15 materials. , 2006, The journal of physical chemistry. B.

[28]  Bradley F. Chmelka,et al.  Nonionic Triblock and Star Diblock Copolymer and Oligomeric Surfactant Syntheses of Highly Ordered, Hydrothermally Stable, Mesoporous Silica Structures , 1998 .

[29]  R. Tan,et al.  Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties. , 2010, Journal of pharmaceutical sciences.

[30]  Wendy I. Wilson,et al.  Investigation of drug-porous adsorbent interactions in drug mixtures with selected porous adsorbents. , 2007, Journal of pharmaceutical sciences.

[31]  Wei-hai Shi,et al.  Ordered large-pore mesoporous silica film with Im3m symmetry synthesized in ternary copolymer–butanol–water system , 2006 .

[32]  M. Vallet‐Regí,et al.  Bioceramics and pharmaceuticals: A remarkable synergy , 2007 .

[33]  Yasuhiro Sakamoto,et al.  Direct imaging of the pores and cages of three-dimensional mesoporous materials , 2000, Nature.

[34]  Joël Patarin,et al.  Morphology and porosity characteristics control of SBA-16 mesoporous silica. Effect of the triblock surfactant Pluronic F127 degradation during the synthesis , 2005 .

[35]  Dongyuan Zhao,et al.  Hexagonal to Mesocellular Foam Phase Transition in Polymer-Templated Mesoporous Silicas , 2000 .

[36]  P. Voort,et al.  Rationalization of the Synthesis of SBA-16: Controlling the Micro- and Mesoporosity , 2002 .

[37]  Dongyuan Zhao,et al.  Morphological Control of Highly Ordered Mesoporous Silica SBA-15 , 2000 .

[38]  V. S. Lin,et al.  Mesoporous silica nanoparticles deliver DNA and chemicals into plants. , 2007, Nature nanotechnology.

[39]  M. Vallet‐Regí,et al.  Influence of pore size of MCM-41 matrices on drug delivery rate , 2004 .

[40]  M. Vallet‐Regí,et al.  A New Property of MCM-41: Drug Delivery System , 2001 .

[41]  I. Smirnova,et al.  Dissolution Rate Enhancement by Adsorption of Poorly Soluble Drugs on Hydrophilic Silica Aerogels , 2005, Pharmaceutical development and technology.

[42]  Brian G. Trewyn,et al.  Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration , 2008 .

[43]  R. Forbes,et al.  Disorder and dissolution enhancement: deposition of ibuprofen on to insoluble polymers. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[44]  Shaobin Wang,et al.  Ordered mesoporous materials for drug delivery , 2009 .

[45]  Y. Sakamoto,et al.  Immobilization of lipase in ordered mesoporous materials: Effect of textural and structural parameters , 2008 .

[46]  Shilun Qiu,et al.  Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica , 2006 .

[47]  G. Mul,et al.  Evaluation of Mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 Materials as API Carriers for Oral Drug Delivery , 2007, Drug delivery.

[48]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[49]  Patrick Augustijns,et al.  Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[50]  V. Crocellà,et al.  Controlled release of metoprolol tartrate from nanoporous silica matrices , 2010 .

[51]  V. Meynen,et al.  Verified syntheses of mesoporous materials , 2009 .

[52]  Patrick Augustijns,et al.  Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs. , 2009, Journal of pharmaceutical sciences.

[53]  J. Devoisselle,et al.  Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[54]  S. Qiu,et al.  A controlled release of ibuprofen by systematically tailoring the morphology of mesoporous silica materials , 2006 .

[55]  C Rossi,et al.  Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[56]  Qiang Cai,et al.  Dilute solution routes to various controllable morphologies of MCM-41 silica with a basic medium , 2001 .